Kevin Coveney
2023
In 2023, Kevin Coveney earned a total compensation of $358.7K as Chief Financial Officer at Enveric Biosciences.
Compensation breakdown
| Salary | $308,989 |
|---|---|
| Stock Awards | $49,688 |
| Total | $358,677 |
Coveney received $309K in salary, accounting for 86% of the total pay in 2023.
Coveney also received $49.7K in stock awards.
Rankings
In 2023, Kevin Coveney's compensation ranked 2,381st out of 3,006 executives tracked by ExecPay. In other words, Coveney earned more than 20.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,381 out of 3,006 | 21st |
Division Manufacturing | 1,339 out of 1,650 | 19th |
Major group Chemicals And Allied Products | 789 out of 918 | 14th |
Industry group Drugs | 770 out of 881 | 13th |
Industry Pharmaceutical Preparations | 554 out of 637 | 13th |
Source: SEC filing on April 16, 2024.
Coveney's colleagues
We found three more compensation records of executives who worked with Kevin Coveney at Enveric Biosciences in 2023.